Surrozen, Inc. - stock earnings
SRZN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -10.4 million USD | ? USD |
| 2023Q2 | -9.4 million USD | ? USD |
| 2023Q1 | -15.9 million USD | ? USD |
| 2022Q4 | 7.3 million USD | 12.5 million USD |
| 2022Q3 | -13.1 million USD | ? USD |
| 2022Q2 | -13.8 million USD | ? USD |
| 2022Q1 | -1.4 million USD | ? USD |
| 2021Q4 | -15.0 million USD | ? USD |
| 2021Q3 | -14.0 million USD | ? USD |
| 2021Q2 | -12.7 million USD | ? USD |
| 2021Q1 | -13.0 million USD | ? USD |
| 2020Q4 | -8.6 million USD | ? USD |
| 2020Q3 | -8.6 million USD | ? USD |
SRZN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -34.9 million USD | 12.5 million USD |
| 2022 | -27.7 million USD | 12.5 million USD |
| 2021 | -52.5 million USD | ? USD |
| 2020 | -32.6 million USD | ? USD |
| 2019 | -24.4 million USD | ? USD |
SRZN
Price: $10.76
52 week price:
Earnings Per Share: -19.75 USD
P/E Ratio: -0.51
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 41336
Market Capitalization: 22.6 million